Time to peak serum antibody response to influenza vaccine

S. Rastogi; P. A. Gross; J. Bonelli; S. Dran; R. A. Levandowski; C. Russo; M. E. Weksler; D. Kaye; M. levison; E. Abrutyn; D. Murasko; J. Mossey; S. Deichmiller; R. Hilsen

doi:10.1128/cdli.2.1.120-121.1995

Time to peak serum antibody response to influenza vaccine

S. Rastogi, P. A. Gross, J. Bonelli, S. Dran, R. A. Levandowski, C. Russo, M. E. Weksler, D. Kaye, M. levison, E. Abrutyn, D. Murasko, J. Mossey, S. Deichmiller, R. Hilsen

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Abstract

The time to the appearance of a peak serum antibody response to influenza virus vaccine is not clearly defined. We compared the most commonly used time intervals described in the literature - 4 and 6 weeks after vaccination. We studied 118 elderly patients from three different geographic sites. The 1992 to 1993 trivalent inactivated influenza virus vaccine containing influenza virus A/Beijing 353/89 (H3N2), influenza virus A/Texas/36/91 (H1N1), and influenza virus B/Panama/45/90 was used. No statistically significant differences were found at the 4- and 6-week intervals after vaccination.

Original language	English
Pages (from-to)	120-121
Number of pages	2
Journal	Clinical and Diagnostic Laboratory Immunology
Volume	2
Issue number	1
DOIs	https://doi.org/10.1128/cdli.2.1.120-121.1995
State	Published - 1995
Externally published	Yes

Access to Document

10.1128/cdli.2.1.120-121.1995

Cite this

@article{eab434d764064f09a8976baf71c07f76,

title = "Time to peak serum antibody response to influenza vaccine",

abstract = "The time to the appearance of a peak serum antibody response to influenza virus vaccine is not clearly defined. We compared the most commonly used time intervals described in the literature - 4 and 6 weeks after vaccination. We studied 118 elderly patients from three different geographic sites. The 1992 to 1993 trivalent inactivated influenza virus vaccine containing influenza virus A/Beijing 353/89 (H3N2), influenza virus A/Texas/36/91 (H1N1), and influenza virus B/Panama/45/90 was used. No statistically significant differences were found at the 4- and 6-week intervals after vaccination.",

author = "S. Rastogi and Gross, {P. A.} and J. Bonelli and S. Dran and Levandowski, {R. A.} and C. Russo and Weksler, {M. E.} and D. Kaye and M. levison and E. Abrutyn and D. Murasko and J. Mossey and S. Deichmiller and R. Hilsen",

year = "1995",

doi = "10.1128/cdli.2.1.120-121.1995",

language = "English",

volume = "2",

pages = "120--121",

journal = "Clinical and Diagnostic Laboratory Immunology",

issn = "1071-412X",

publisher = "American Society for Microbiology",

number = "1",

}

TY - JOUR

T1 - Time to peak serum antibody response to influenza vaccine

AU - Rastogi, S.

AU - Gross, P. A.

AU - Bonelli, J.

AU - Dran, S.

AU - Levandowski, R. A.

AU - Russo, C.

AU - Weksler, M. E.

AU - Kaye, D.

AU - levison, M.

AU - Abrutyn, E.

AU - Murasko, D.

AU - Mossey, J.

AU - Deichmiller, S.

AU - Hilsen, R.

PY - 1995

Y1 - 1995

N2 - The time to the appearance of a peak serum antibody response to influenza virus vaccine is not clearly defined. We compared the most commonly used time intervals described in the literature - 4 and 6 weeks after vaccination. We studied 118 elderly patients from three different geographic sites. The 1992 to 1993 trivalent inactivated influenza virus vaccine containing influenza virus A/Beijing 353/89 (H3N2), influenza virus A/Texas/36/91 (H1N1), and influenza virus B/Panama/45/90 was used. No statistically significant differences were found at the 4- and 6-week intervals after vaccination.

AB - The time to the appearance of a peak serum antibody response to influenza virus vaccine is not clearly defined. We compared the most commonly used time intervals described in the literature - 4 and 6 weeks after vaccination. We studied 118 elderly patients from three different geographic sites. The 1992 to 1993 trivalent inactivated influenza virus vaccine containing influenza virus A/Beijing 353/89 (H3N2), influenza virus A/Texas/36/91 (H1N1), and influenza virus B/Panama/45/90 was used. No statistically significant differences were found at the 4- and 6-week intervals after vaccination.

UR - http://www.scopus.com/inward/record.url?scp=0028842039&partnerID=8YFLogxK

U2 - 10.1128/cdli.2.1.120-121.1995

DO - 10.1128/cdli.2.1.120-121.1995

M3 - Article

C2 - 7719904

AN - SCOPUS:0028842039

SN - 1071-412X

VL - 2

SP - 120

EP - 121

JO - Clinical and Diagnostic Laboratory Immunology

JF - Clinical and Diagnostic Laboratory Immunology

IS - 1

ER -

Time to peak serum antibody response to influenza vaccine

Abstract

Access to Document

Fingerprint

Cite this